Rep. Steube: Trump is Right, Time to Reschedule Marijuana
WASHINGTON, D.C. — U.S. Representative Greg Steube (R-Fla.) issued the following statement today, praising President Trump’s support for rescheduling marijuana and calling for Congress to take up his Marijuana 1-to-3 Act:
“President Trump is right. Now is the time to reclassify marijuana, and the Drug Enforcement Administration must open the door for scientific research into the plant’s medicinal value,” said Rep. Steube. “My Marijuana 1-to-3 Act will deliver exactly what President Trump has requested: legislation that moves marijuana from Schedule I to Schedule III under the Controlled Substances Act. This bill will create new opportunities for scientists and physicians to develop treatments and cures for pain and disease. I am grateful for the White House’s leadership on this issue and call on my colleagues in Congress to bring the Marijuana 1-to-3 Act to the House floor immediately.”
Background: This legislation orders the Drug Enforcement Administration to move marijuana from Schedule I to Schedule III as defined under the Controlled Substances Act. Reassigning marijuana to Schedule III will permit federal funding for research on the medicinal value of marijuana.
The Marijuana 1-to-3 Act has the support of the US Cannabis Roundtable, the Veterans Cannabis Project, Management Science Associates, the National Cannabis Industry Association, and the National Organization for the Reform of Marijuana Laws.
“The U.S. Cannabis Roundtable strongly supports Representative Greg Steube’s (R-FL) reintroduction of the Marijuana 1-to-3 Act, which would move cannabis from Schedule I to Schedule III under the Controlled Substances Act.
“Congressman Steube is absolutely right — it makes no sense that federal law treats marijuana the same as heroin and LSD, and even more absurd that cocaine is classified less restrictively than marijuana. This is a common-sense, science-based reform that would finally unlock real medical research, improve care for patients and veterans, and modernize our outdated drug laws — all while maintaining existing safeguards to protect children and young people.
“We are encouraged that leading House Republicans are championing this effort and urge members of Congress from both parties to support this legislation. Rescheduling cannabis is not a partisan issue — it’s about advancing science, strengthening public health, and reflecting the realities recognized in communities across America. —US Cannabis Roundtable
“Veterans across the country have borne the brunt of outdated laws that treat medical marijuana the same as heroin. Representative Steube’s Marijuana 1-to-3 Act is a long overdue and commonsense reform that will allow real scientific research into cannabis’ therapeutic potential, improve safety standards, and give veterans access to treatments without fear of legal or regulatory fallout. We applaud Rep. Steube’s leadership in introducing this bill — it’s the kind of policy that puts veterans first, restores evidence-based decision making, and finally begins to align federal law with what medical science, state programs, and veterans themselves already know to be true.” —Nick Etten, Founder of Veterans Cannabis Project
“Management Science Associates, Inc. applauds the Administration’s recent announcement to reclassify cannabis as a Schedule III substance. We also commend Representative Greg Steube for reintroducing the Marijuana 1-to-3 Act (H.R. 4963), which would help eliminate longstanding federal barriers and significantly expand access to critical cannabis research. Efforts like these lay the foundation for a more robust regulatory framework and enable cannabis businesses to invest with greater confidence in science, innovation, and evidence-based practices. These developments are vital to fostering a responsible, data-driven industry centered on public health and wellness.” —Management Science Associates, Inc.
“NCIA commends Rep. Steube for his continued leadership on this issue. The Congressman’s Marijuana 1-to-3 Act would alleviate the punitive burden that is IRC Section 280E, however, further reforms are needed. NCIA urges the administration to move swiftly and transparently toward a science-based outcome that recognizes cannabis’ medical value and eases the burdens that businesses face under outdated federal law. At the same time, we call on Congress to enact legislation that tracks with a public that overwhelmingly supports making cannabis legal for adults, protecting our industry and upholding public safety in the process.” —Michelle Rutter Friberg, Director of Government Relations for the National Cannabis Industry Association
“This timely legislation corrects the absurdity of classifying cannabis as a Schedule I substance and helps pave the way for sensible, evidence-based federal cannabis policy. Moving cannabis to Schedule III is an overdue recognition of its established medical value, and will allow state-licensed cannabis providers to better compete against underground operators to ensure that consumers have access to tested, reliable, and affordable products.” —Morgan Fox, Political Director for the National Organization for the Reform of Marijuana Laws (NORML)
Read the full bill text here.